A Phase III Randomized Controlled Trial of Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Minimally Invasive Esophagectomy or Robot-assisted Minimally Invasive Esophagectomy

The design of this trial led to early stopping because the short-term results indicated that outcomes in the pyloroplasty arm were superior to the no-pyloroplasty arm. This RCT provides evidence for short-term benefits of adding pyloroplasty to MIE or RAMIE. The long-term outcomes and quality of life measures continue to be monitored.

Authors

Institutions

Publication Details

Journal
Annals of Surgery
Published
2025-12-19
DOI
https://doi.org/10.1097/sla.0000000000006997
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase III Randomized Controlled Trial of Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Minimally Invasive Esophagectomy or Robot-assisted Minimally Invasive Esophagectomy

James D. Luketich, William E. Gooding, Evan T. Alicuben, Julie Ward et al.
Annals of Surgery
Esophageal Cancer Research and Treatment
article

A Phase III Randomized Controlled Trial of Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Minimally Invasive Esophagectomy or Robot-assisted Minimally Invasive Esophagectomy

James D. Luketich, William E. Gooding, Evan T. Alicuben, Julie Ward, Ryan M. Levy, Renée Lévesque, Arjun Pennathur, Peter G. Davis, Omar Awais, Matthew J. Schuchert, Inderpal S. Sarkaria, John P. Ryan, Neil A. Christie
article en

Abstract

The design of this trial led to early stopping because the short-term results indicated that outcomes in the pyloroplasty arm were superior to the no-pyloroplasty arm. This RCT provides evidence for short-term benefits of adding pyloroplasty to MIE or RAMIE. The long-term outcomes and quality of life measures continue to be monitored.

Annals of SurgeryVol. 283(4)
Cancer Research And Biostatistics (US), UPMC Hillman Cancer Center (US), University of Pittsburgh Medical Center (US)
Openalex Percentile: Top 39%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.